absalom01 I went back to this post to see if I could find what source Steve Van Doorn was using as his “authority”.
It turns out to be another July 2020 paper churned out by “Languages and Linguistics” guy jean-claude Perez, who on this paper says he is a “PhD in Maths and Computer Science”.
https://independent.academia.edu/Perezjeanclaude
And it’s posted at the same pay to play site as the other paper, ResearchGate.net .
So Steve’s authoritative source is some retired “maths and computer science” guy who doesn’t claim any medical education, much less the genetics specialty that he’s expounding on in this paper. Plus he’s posting it on a non-peer reviewed site that no one in the actual world of medical research uses.
Pretty convincing stuff. I bet a Nobel Prize in Medicine is awaiting the polymath jean-claude Perez. Or not.
https://www.researchgate.net/about
OUR BUSINESS
How we make money.
It is researchers who create value for everybody who uses the ResearchGate platform. Our commitment to serving the researcher community also informs our business decisions.
For most of our existence, we’ve been an investor-funded startup. This model has allowed us to focus on building a great product and expand our network to the 20+ million researchers we have today.
Our aim is to mature into a business that can deliver on our mission far into the future. This means finding new ways to maintain a sustainable business while prioritizing the needs of the researcher. We developed our marketing and recruitment services with this goal in mind.
How can a lab manager find the best new equipment for their facility? How can a postdoc find a job that perfectly matches their specific skill set? Our platform connects the people who make science happen with the companies and institutions that make science possible. In turn, these aspects of our business help keep our network free of charge for researchers.
We never forget that our members create value in the network. Therefore, in all our decisions about our business, we put the researcher first, and our purpose above our profits.